Drug Profile
Amlodipine/enalapril
Alternative Names: Amlodipine/enalapril maleate; GSK2944404Latest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antihypertensives; Dihydropyridines; Dipeptides
- Mechanism of Action ACE inhibitors; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 30 May 2013 GlaxoSmithKline completes a phase I trial in Healthy volunteers in Australia (NCT01822639)
- 30 Apr 2013 Phase-I clinical trials in Hypertension in Australia (PO)